Stuart W. Peltz

2018

In 2018, Stuart W. Peltz earned a total compensation of $4M as Chief Executive Officer at PTC Therapeutics, a 85% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$922,347
Option Awards$2,421,961
Salary$658,819
Other$13,608
Total$4,016,735

Peltz received $2.4M in option awards, accounting for 60% of the total pay in 2018.

Peltz also received $922.3K in non-equity incentive plan, $658.8K in salary and $13.6K in other compensation.

Rankings

In 2018, Stuart W. Peltz's compensation ranked 2,771st out of 14,244 executives tracked by ExecPay. In other words, Peltz earned more than 80.5% of executives.

ClassificationRankingPercentile
All
2,771
out of 14,244
81st
Division
Manufacturing
1,027
out of 5,758
82nd
Major group
Chemicals And Allied Products
353
out of 2,119
83rd
Industry group
Drugs
290
out of 1,808
84th
Industry
Pharmaceutical Preparations
223
out of 1,382
84th
Source: SEC filing on April 25, 2019.

Peltz's colleagues

We found four more compensation records of executives who worked with Stuart W. Peltz at PTC Therapeutics in 2018.

2018

Marcio Souza

PTC Therapeutics

Chief Operating Officer

2018

Neil Almstead

PTC Therapeutics

Chief Technical Operations Officer

2018

Mark Boulding

PTC Therapeutics

Chief Legal Officer

2018

Christine Utter

PTC Therapeutics

Principal Financial Officer and Treasurer

News

In-depth

You may also like